Anti‐diabetic effects of GLP ‐1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: A systematic review

Documenti analoghi

• COMMUNITY AND PUBLIC HEALTH INTERVENTIONS FOR FALL PREVENTION IN BRUNEI
  di: Shyh Poh Teo
  Pubblicazione: (2020)
• Oral health for healthy aging
  di: Shyh Poh Teo
  Pubblicazione: (2021)
• DEMENTIA REGISTRIES HAVE SIGNIFICANT POTENTIAL TO IMPROVE DEMENTIA RESEARCH
  di: Shyh Poh Teo
  Pubblicazione: (2020)
• The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system
  di: Deshan Sebaratnam, et al.
  Pubblicazione: (2025)
• Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial
  di: Joanna Y. Gong, et al.
  Pubblicazione: (2025)